| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Mohit Kaushal is Director at TOI and has filed Form 4s across 3 companies. Mohit Kaushal's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $126K at current prices.
Historically, Mohit Kaushal's trades have earned a middling insider score of 51/100 across 4 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +26.7%.
The biggest single holding is AHCO (~$126K) as Director.
Mohit Kaushal has 13 Form 4 filings on record from April 2018 to July 2026, across 3 companies: Director at The Oncology Institute (TOIIW), 2026; Director at Oncology Institute (TOI), 2021–2025; Director at AdaptHealth (AHCO), 2018–2019.
The 17 reported transactions were 9 stock awards, 4 open-market sales, 2 other transactions and 1 conversion, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $393K.
The largest open-market sale was 95,719 shares of TOIIW at an average $3.50 on April 16, 2026, about $335K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | TOIIW The Oncology Institute, Inc. | Director | Sell10b5-1 | 95,719 | $3.50 | $335,133.10 | -35.7% | +26.7% | - | |
| Nov 14, 2022 | TOI Oncology Institute, Inc. | Director | Sell | 15,994 | $2.13 | $34,083.21 | -38.5% | -27.3% | +15.3% | |
| Oct 24, 2022 | TOI Oncology Institute, Inc. | Director | Sell | 4,798 | $4.96 | $23,798.08 | -10.4% | -71.1% | -68.7% |